Goldman Sachs Is Taking its Medicine. That’s Good News for Shareholders.
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
After seeing its consumer banking efforts struggle immensely in recent years, the investment banking powerhouse Goldman Sachs (NYSE: GS) announced at its investor day in February that it would pull back from its consumer banking ambitions, which it launched in 2016.
:max_bytes(150000):strip_icc():format(jpeg)/sign-reading-for-sale-by-owner-outside-single-family-home-200256006-001-579798553df78ceb8672372a.jpg)
" title=":max_bytes(150000):strip_icc():format(jpeg)/GettyImages-111661701-fc3fd2dede3f4574866dba051b67473a.jpg "How an All-Cash Offer Can Help You Win a Bidding War")
